Trelegy ellipta 100-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB25FK3XT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,621
Award facts
- Contract value 100% obligated
- $14,621.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder in 60-dose units. This competitively awarded, non-set-aside contract carries a ceiling value of $14,621.24 and a firm fixed price structure, with an ultimate completion date of July 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026.
The SPE2DX prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen Drug Corp to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. Trelegy Ellipta is a combination inhaled medication used for chronic obstructive pulmonary disease management, reflecting the company's role in delivering specialized therapeutic medications across multiple clinical domains to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen Drug Corp's extensive portfolio of federal medical procurement contracts demonstrates its capability to meet diverse military healthcare supply requirements through open competition.
Quick answers
Who was awarded contract SPE2DB25FK3XT?
SPE2DB25FK3XT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FK3XT worth?
The government has obligated $14,621 on SPE2DB25FK3XT.
Is contract SPE2DB25FK3XT an order under another contract?
Yes. SPE2DB25FK3XT is a delivery order under SPE2DB22D3019, an indefinite delivery contract.
Was contract SPE2DB25FK3XT competed?
The extent of competition for SPE2DB25FK3XT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award